PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
	For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Diltiazem hydrochloride - Hypertension
PAD Profile : Diltiazem hydrochloride - Hypertension Important
Keywords : 
                        Branded prescribing, prescribing by brand, branded generics
                    Brand Names Include : 
                        Adizem SR, Adizem XL, Angitil SR, Angitil XL, Dilcardia SR, Calcicard CR, Dilzem SR, Dilzem XL, Slozem, Tildiem LA, Tildiem retard, Tildiem SR, Viazem XL, Zemtard, Kenzem SR
                    Important Information : 
                        Prescribe by BRAND
                    Traffic Light Status
Status 1 of 2.
Status : 
                    Green
                             Important
                            Formulations : 
                            - Modified release tablets
Important Information : 
                        Tildiem Retard (TWICE daily) are the lowest cost brand in Primary Care for patients requiring a tablet formulation.
                    Trust Alignment : 
                    Primary Care
                                ASPH
                                RSFT
                                SASH
                                SABP
                                Comments : 
                    
                            No comments returned.
                    
                Documents : 
                    Status 2 of 2.
Status : 
                    Green
                             Important
                            Formulations : 
                            - Modified release capsules
Important Information : 
                        Angitil SR capsules (TWICE daily) or Zemtard XL or Slozem (ONCE daily) are the lowest cost brands for Primary Care.
                    Trust Alignment : 
                    Primary Care
                                ASPH
                                RSFT
                                SASH
                                SABP
                                Comments : 
                    
                            No comments returned.
                    
                Documents : 
                    Guidelines
The following guidelines are available for this indication.
Other Drugs
- Aliskiren
- Bendroflumethiazide
- Candesartan cilexetil
- Eprosartan
- Indapamide
- Irbesartan
- Losartan potassium
- Olmesartan medoxomil
- Valsartan
- Ramipril
- Amlodipine
- Lisinopril
- Bisoprolol fumarate
- Doxazosin mesilate
- Nifedipine
- Perindopril erbumine
- Telmisartan
- Lisinopril / Hydrochlorothiazide
- Moxonidine
- Irbesartan / Hydrochlorothiazide
- Valsartan with hydrochlorothiazide
- Co-tenidone (Atenolol/chlortalidone)
- Enalapril maleate
- Quinapril hydrochloride
- Nebivolol
- Perindopril arginine
- Metolazone
- Azilsartan medoxomil
- Captopril
- Lercanidipine hydrochloride
- Nicardipine hydrochloride
- Chlortalidone
- Spironolactone
- Atenolol
- Carvedilol
- Celiprolol hydrochloride
- Metoprolol tartrate
- Propranolol hydrochloride
- Prazosin hydrochloride
- Clonidine hydrochloride
- Hydralazine hydrochloride
Other Indications
Additional Documents
Type
                            Document
                            Review Date
                        Committee Recommendations
Date
                            Committee Name
                            Narrative
                        02 September 2015
                                Surrey Medicines Commissioners Group
                                It is recommended that slow-release and longer-acting diltiazem products are prescribed by brand.
Following consideration of product price and current prescribing levels, the following were agreed as cost-effective preferred diltiazem brands for primary care:
- Twice daily – Angitil SR capsules (available in all three strengths)
- OR Tildiem Retard for patients preferring a tablet (although not available as 180mg strength)
- Once daily – Zemtard XL
Associated BNF Codes
02. Cardiovascular System
                            02.06.02. Calcium-channel blockers